BeStock  
Stocks › Biotechnology › ATTO

Attovia Therapeutics ATTO

US equityMarket cap rank #3395Biotechnology
$15.10 −$0.48 (-3.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $15.10 0.00%
Open$15.40
Prev close$15.58
Day range$14.80 – $15.46
Volume372.2K
Market cap$690.26M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00-100.0% YoY
Operating profit-$25.02M-60.4% YoY
Net profit-$22.27M-61.6% YoY
Diluted EPS-$0.76-41.6% YoY
Free cash flow-$25.69M-65.4% YoY
Operating cash flow-$25.67M

Revenue, last 8 quarters

$346.8MSep '22$0.0Mar '25$0.0Jun '25$360.0KSep '25$990.0KDec '25$0.0Mar '26$450.0KJun '26$0.0Sep '26

Net profit, last 8 quarters

$1.5MSep '22$-15.2MMar '25$-14.4MJun '25$-13.8MSep '25$-17.3MDec '25$-18.7MMar '26$-20.7MJun '26$-22.3MSep '26

Diluted EPS by quarter

0.10Sep '22-0.60Mar '25-0.56Jun '25-0.54Sep '25-0.67Dec '25-0.73Mar '26-0.48Jun '26-0.76Sep '26

Free cash flow by quarter

$-12.4MSep '22$-15.9MMar '25$-12.7MJun '25$-15.5MSep '25$-17.4MDec '25$-18.4MMar '26$-16.9MJun '26$-25.7MSep '26

Annual revenue

$1.8BFY18$1.7BFY19$1.4BFY20$1.4BFY21$0.0FY24$1.4MFY25

Profitability & balance sheet

Operating margin-5,945.5%
Net margin-5,477.2%
Return on equity-19.8%
Return on assets-19.2%
Return on invested capital-21.3%
Current ratio34.66
Liabilities / assets3.4%
Cash & investments$395.94M
Total debt$1.74M
Net cash (debt)$394.20M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $0.00 $450,000.00 – $1.35M $990,000.00
Total Operating Revenue $0.00 $450,000.00 $0.00 $1.35M $990,000.00
Operating Expense $25.02M $22.25M $19.96M $68.51M $19.82M
Selling and Admin Expenses $4.73M $3.31M $3.21M $14.36M $3.43M
-General & Admin Expense $4.73M $3.31M $3.21M $14.36M $3.43M
Research & Development $20.29M $18.95M $16.75M $54.15M $16.39M
Operating Profit -$25.02M -$21.80M -$19.96M -$67.16M -$18.83M
Net Non-Operating Interest Income (Expense) $2.79M $1.14M $1.33M $6.63M $1.61M
Non-Operating Interest Income $2.79M $1.14M $1.33M $6.63M $1.61M
Other Income (Expense) -$34,000.00 -$25,000.00 -$27,000.00 -$95,000.00 -$30,000.00
Other Non-Operating Income (Expenses) -$34,000.00 -$25,000.00 -$27,000.00 -$95,000.00 -$30,000.00
Pretax Profit -$22.27M -$20.69M -$18.66M -$60.63M -$17.26M
Net Profit -$22.27M -$20.69M -$18.66M -$60.63M -$17.26M
Profit from Continuing Operations -$22.27M -$20.69M -$18.66M -$60.63M -$17.26M
Net Income to Parent Company -$22.27M -$20.69M -$18.66M -$60.63M -$17.26M
Other Preferred Stock Dividends $0.00 $0.00 $0.00 $271,000.00 $0.00
Net Income to Common Stockholders -$22.27M -$20.69M -$18.66M -$60.90M -$17.26M
Basic EPS -$0.76 -$0.48 -$0.73 -$2.37 -$0.67
Diluted EPS -$0.76 -$0.48 -$0.73 -$2.37 -$0.67

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $411.82M $128.35M $146.09M $165.89M $165.89M
Total Current Assets $404.52M $118.40M $136.64M $156.30M $156.30M
Cash and Cash Equivalents & Short-Term Investments $395.94M $115.13M $132.62M $152.27M $152.27M
-Cash and Cash Equivalents $115.37M $32.83M $43.30M $40.19M $40.19M
-Short Term Investments $280.57M $82.30M $89.33M $112.08M $112.08M
Other Current Assets $8.58M $3.27M $4.02M $4.03M $4.03M
Total Non-Current Assets $7.31M $9.95M $9.44M $9.60M $9.60M
Net PPE $6.32M $6.92M $7.49M $7.87M $7.87M
-Gross PPE $8.15M $8.51M $8.83M $8.96M $8.96M
-Accumulated Depreciation -$1.83M -$1.59M -$1.34M -$1.10M -$1.10M
Other Non-Current Assets $990,000.00 $3.03M $1.95M $1.73M $1.73M
Total Liabilities $14.08M $273.81M $271.60M $273.33M $273.33M
Total Current Liabilities $11.67M $12.62M $9.80M $11.01M $11.01M
Payables $4.23M $6.00M $2.56M $3.55M $3.55M
-Accounts Payable $4.23M $6.00M $2.56M $3.55M $3.55M
Current Accrued Expenses $2.45M $2.67M $3.52M $1.98M $1.98M
Short-Term Debt and Capital Lease Obligation $2.10M $2.04M $1.98M $1.92M $1.92M
-Current Capital Lease Obligation $2.10M $2.04M $1.98M $1.92M $1.92M
Current Deferred Liabilities $0.00 $0.00 $450,000.00 $450,000.00 $450,000.00
Total Non-Current Liabilities $2.41M $261.19M $261.80M $262.32M $262.32M
Long Term Debt and Capital Lease Obligation $1.74M $2.29M $2.83M $3.34M $3.34M
-Long Term Capital Lease Obligation $1.74M $2.29M $2.83M $3.34M $3.34M
Convertible preferred securities $0.00 $258.23M $258.23M $258.23M $258.23M
Other Non-Current Liabilities $672,000.00 $678,000.00 $750,000.00 $755,000.00 $755,000.00
Total Equity $397.74M -$145.46M -$125.52M -$107.44M -$107.44M
Stockholders' Equity $397.74M -$145.46M -$125.52M -$107.44M -$107.44M
Capital Stock $5,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-Common Stock $5,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
Additional Paid-In Capital $570.91M $4.97M $4.18M $3.47M $3.47M
Retained Earnings -$172.62M -$150.35M -$129.67M -$111.01M -$111.01M
Gains/Losses Not Affecting Retained Earnings -$548,000.00 -$79,000.00 -$27,000.00 $99,000.00 $99,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$25.67M -$16.79M -$18.14M -$59.20M -$17.34M
Net cash flow from continuing operations -$25.67M -$16.79M -$18.14M -$59.20M -$17.34M
Net Income from Continuing Operations -$22.27M -$20.69M -$18.66M -$60.63M -$17.26M
Depreciation & Depletion & Amortization $248,000.00 $246,000.00 $242,000.00 $804,000.00 $231,000.00
Other Non-Cash Items $411,000.00 $402,000.00 $393,000.00 $48,000.00 -$605,000.00
Change in Working Capital -$5.50M $2.64M -$541,000.00 $276,000.00 $105,000.00
-Change in Prepaid Assets -$4.12M $850,000.00 $122,000.00 -$420,000.00 -$932,000.00
-Change in Payables and Accrued Expense -$373,000.00 $2.25M -$216,000.00 $1.30M $1.20M
-Change in Other Current Assets -$511,000.00 $14,000.00 $11,000.00 -$98,000.00 $11,000.00
-Change in Other Current Liabilities -$488,000.00 -$478,000.00 -$458,000.00 -$509,000.00 -$169,000.00
Net cash flow from investing -$199.75M $6.88M $22.49M -$73.46M $7.74M
Net Cash Flow from Continuing Investing Activities -$199.75M $6.88M $22.49M -$73.46M $7.74M
Net PPE Purchase and Sale -$17,000.00 -$73,000.00 -$288,000.00 -$2.31M -$52,000.00
Net Investment Purchase and Sale -$199.73M $6.95M $22.77M -$71.14M $7.79M
Financing Cash Flow $307.96M -$556,000.00 -$1.24M $142.01M $33,000.00
Net Cash Flow from Continuing Financing Activities $307.96M -$556,000.00 -$1.24M $142.01M $33,000.00
Net Common Stock Issuance $309.37M $31,000.00 $11,000.00 $194,000.00 $34,000.00
Net Preferred Stock Issuance $0.00 $0.00 $0.00 $142.19M $0.00
Net Other Financing Charges -$1.41M -$587,000.00 -$1.25M -$376,000.00 -$1,000.00
Ending Cash Balance $115.77M $33.23M $43.70M $40.60M $40.60M
Net Change in Cash $82.54M -$10.47M $3.10M $9.36M -$9.57M
Beginning Cash Balance $33.23M $43.70M $40.60M $31.24M $50.17M
Free Cash Flow -$25.69M -$16.86M -$18.43M -$61.51M -$17.40M
Gain/Loss from Continuing Operations – – – $7,000.00 $0.00
Net Issuance Payments Of Debt – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on ATTO.

Sign in to join the discussion.

Scroll to Top